Brief: Medipharm Labs Announces Increase To Bought Deal Equity Financing To $29 Million
02/03/2021 14:19
March 2 (Reuters) - Medipharm Labs Corp LABS.TO :
* MEDIPHARM LABS ANNOUNCES INCREASE TO BOUGHT DEAL EQUITY
FINANCING TO $29 MILLION
* MEDIPHARM LABS CORP - UNDERWRITERS HAVE AGREED TO
PURCHASE, ON A
BOUGHT DEAL BASIS, 50 MILLION UNITS OF CO AT A PRICE OF $0.58
PER UNIT
* MEDIPHARM LABS CORP - EACH UNIT WILL BE COMPRISED OF ONE
COMMON
SHARE IN CAPITAL OF CO AND ONE SHARE PURCHASE WARRANT
Source text for Eikon: ID:nGNX5t8b6
Further company coverage: LABS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medipharm Labs
See all newsCanada's MediPharm Labs Q2 revenue rises 11% on international growth
Brief: MediPharm Labs Q2 Revenue CAD 10 Million
Canada's MediPharm Labs reports positive Q1 adjusted EBITDA
Canada's MediPharm Labs FY revenue rises 8% on international sales
Brief: Medipharm Labs Reports Full Year & Fourth Quarter 2025 Results With Over 40% Annual Growth In International Medical Revenue